Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer

NCT01409811 is registered in ClinicalTrials.gov with City of Hope Medical Center as lead sponsor.

NCT NCT01409811
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01409811 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Pilot Study of the Impact of a Single Dose of Zoledronic Acid on Biomarkers in Breast Cancer
Lead sponsor
City of Hope Medical Center
Phase
Not applicable
Overall status
Terminated
Start date
September 14, 2012
Completion date
February 28, 2015
Enrollment
9 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

estrogen receptor-positive breast cancer, invasive ductal breast carcinoma, progesterone receptor-positive breast cancer, stage ia breast cancer, stage ib breast cancer, stage iia breast cancer, stage iib breast cancer